SEC filing · 8-K

Rocket Pharmaceuticals, Inc.: Material agreement

Rocket Pharmaceuticals entered into a loan agreement with Hercules Capital for up to $150.0 million in senior secured term loans.

Filed October 6, 2026

Positive for the company

What happened

Rocket Pharmaceuticals and its subsidiaries entered into a Loan and Security Agreement with lenders and Hercules Capital on September 30, 2026.

The full interpretation is in the app

Why it matters, the key numbers from the document and what to watch next: the full interpretation of every report is part of Pro.

Read the full interpretation

Read the original

Filing document on SEC.gov Press release (EX-99.1) All documents of this filing

Back to Rocket Pharmaceuticals, Inc.

Summary generated automatically from the filing text and checked against it: every number above is printed in the document. It describes the filing and is not investment advice. Read the original before relying on it.